Heart repair drug trial halted before first patient
NCT ID NCT05953831
Summary
This study aimed to test whether an experimental drug called CDR132L could help improve the structure and function of the heart in people with a specific type of heart failure where the heart pumps normally but is stiff and thickened. The trial planned to enroll about 130 patients to compare the drug against a placebo, but it was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH PRESERVED EJECTION FRACTION are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.